Aortic root size is associated with nocturnal blood pressure in a population of hypertensive patients under treatment for obstructive sleep apnea.


Journal

Sleep & breathing = Schlaf & Atmung
ISSN: 1522-1709
Titre abrégé: Sleep Breath
Pays: Germany
ID NLM: 9804161

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 31 01 2018
accepted: 12 07 2018
revised: 28 06 2018
pubmed: 26 7 2018
medline: 22 5 2020
entrez: 26 7 2018
Statut: ppublish

Résumé

Obstructive sleep apnea (OSA) is associated with an increased aortic root size. This association has never been studied in patients with hypertension undergoing continuous positive airway pressure (CPAP) treatment for OSA. The 24-h blood pressure (BP) monitoring of 142 hypertensive patients undergoing CPAP treatment for OSA was prospectively documented. Aortic root diameter was assessed by echocardiography. The population included 33.8% women, with an overall mean age of 60.7 ± 10.5 years. The median body mass index was 32.7 [29. 5-36.3] kg/m In OSA patients, the relationship between aortic root diameter and nocturnal BP persists on CPAP therapy. Further studies that evaluate the potential protective effect of OSA treatment on aortic root dilatation should monitor nocturnal diastolic BP.

Sections du résumé

BACKGROUND BACKGROUND
Obstructive sleep apnea (OSA) is associated with an increased aortic root size. This association has never been studied in patients with hypertension undergoing continuous positive airway pressure (CPAP) treatment for OSA.
METHODS METHODS
The 24-h blood pressure (BP) monitoring of 142 hypertensive patients undergoing CPAP treatment for OSA was prospectively documented. Aortic root diameter was assessed by echocardiography.
RESULTS RESULTS
The population included 33.8% women, with an overall mean age of 60.7 ± 10.5 years. The median body mass index was 32.7 [29. 5-36.3] kg/m
CONCLUSION CONCLUSIONS
In OSA patients, the relationship between aortic root diameter and nocturnal BP persists on CPAP therapy. Further studies that evaluate the potential protective effect of OSA treatment on aortic root dilatation should monitor nocturnal diastolic BP.

Identifiants

pubmed: 30043386
doi: 10.1007/s11325-018-1698-3
pii: 10.1007/s11325-018-1698-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

439-446

Références

JAMA. 2000 Apr 12;283(14):1829-36
pubmed: 10770144
Am J Respir Crit Care Med. 2001 Feb;163(2):344-8
pubmed: 11179104
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):685-9
pubmed: 11254524
Am J Cardiol. 2006 Jan 15;97(2):270-5
pubmed: 16442377
Hypertension. 2007 Aug;50(2):417-23
pubmed: 17548722
Arch Cardiovasc Dis. 2008 Jun;101(6):391-7
pubmed: 18809152
Am J Respir Crit Care Med. 2010 Apr 1;181(7):718-26
pubmed: 20007932
Am J Respir Crit Care Med. 2011 Mar 1;183(5):668-74
pubmed: 20622036
Circulation. 2010 Aug 31;122(9):884-90
pubmed: 20713896
Hypertension. 2011 Nov;58(5):811-7
pubmed: 21968750
Sleep. 2011 Nov 01;34(11):1605-7
pubmed: 22043131
J Clin Sleep Med. 2012 Oct 15;8(5):587-96
pubmed: 23066375
JAMA. 2013 Dec 11;310(22):2407-15
pubmed: 24327037
Blood Press. 2014 Feb;23(1):3-16
pubmed: 24359485
Hypertension. 2014 Feb;63(2):203-9
pubmed: 24379177
Am J Cardiol. 2014 Aug 15;114(4):618-23
pubmed: 25086782
Am J Respir Crit Care Med. 2015 Jul 1;192(1):111-4
pubmed: 26131992
J Am Heart Assoc. 2016 Apr 03;5(4):e002930
pubmed: 27039928
Ann Thorac Surg. 2016 Nov;102(5):1558-1564
pubmed: 27262915
Int J Cardiol. 2016 Nov 15;223:999-1006
pubmed: 27591699
Am J Cardiol. 1989 Sep 1;64(8):507-12
pubmed: 2773795
Sleep. 2017 Mar 01;40(3):null
pubmed: 28364434
Blood Press Monit. 2017 Aug;22(4):208-212
pubmed: 28394772
Am J Cardiol. 2017 Aug 1;120(3):484-488
pubmed: 28583684
J Med Vasc. 2017 May;42(3):162-169
pubmed: 28705405

Auteurs

Pascal Delsart (P)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France. delsartpascal@yahoo.fr.
Vascular Medicine and Hypertension Department, Institut-Coeur-Poumon, Boulevard Pr Leclercq, 59037, Lille Cedex, France. delsartpascal@yahoo.fr.

Jerome Soquet (J)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.
University of Lille, CHU Lille, F-59000, Lille, France.

Elodie Drumez (E)

Department of Biostatistics, Univ. Lille, CHU Lille, EA 2694 - Santé publique : épidémiologie et qualité des soins, F-59000, Lille, France.

Francis Juthier (F)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.
University of Lille, CHU Lille, F-59000, Lille, France.

Seenam Kutoati (S)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.

Thomas Nganou Koutouzi (TN)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.

Stephanie Fry (S)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.

Anne Mallart (A)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.

David Montaigne (D)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.
University of Lille, CHU Lille, F-59000, Lille, France.

Claire Mounier-Vehier (C)

CHU Lille, Institut Cœur Poumon, Bd Pr Leclercq, F-59000, Lille, France.
University of Lille, CHU Lille, F-59000, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH